Suppr超能文献

白花丹醌与庆大霉素联合抗碳青霉烯类耐药菌的协同作用及机制

Synergistic Effect and Mechanism of Plumbagin with Gentamicin Against Carbapenem-Resistant .

作者信息

Chen Xiuli, Yin Liyuan, Peng Linxiu, Liang Yanshan, Lv Hang, Ma Tonghui

机构信息

School of Medicine, Nanjing University of Chinese Medicine, Nanjing 210023, Jiangsu Province, People's Republic of China.

出版信息

Infect Drug Resist. 2020 Aug 7;13:2751-2759. doi: 10.2147/IDR.S265753. eCollection 2020.

Abstract

BACKGROUND

Aminoglycosides are one of a few susceptible antimicrobials available for carbapenem-resistant (CRE). However, the altered pharmacokinetics and increasing drug resistance of aminoglycosides will make them hardly effective if used in monotherapy. The purpose of this study was to identify herbal compounds that potentiate the antibacterial effect of gentamicin against carbapenem-resistant (CRKp) with gentamicin resistance and explore the action mechanisms.

METHODS

A collection of 280 Chinese herbal compounds was screened for synergistic effect with gentamicin against CRKp by broth microdilution method according to the standard of the Clinical and Laboratory Standards Institute (CLSI). Intracellular gentamicin was measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The membrane potential was evaluated by Light Bacterial Membrane Potential Kit. Plumbagin-induced metabolite changes of vital metabolic pathways were measured by an optimized untargeted metabolomics method based on gas chromatography-mass spectrometer (GC/MS). Intracellular nicotinamide adenine dinucleotide (NADH) was detected via EnzyChrom NAD/NADH assay kit.

RESULTS

We identified plumbagin to remarkably potentiate the antimicrobial activity of gentamicin against the CRKp with gentamicin resistance. Plumbagin at 100 μM could bring the MIC of gentamicin from >16 μg/mL to ~4 μg/mL despite its minimal inhibitory effect on the CRKp. A similar synergistic effect with gentamicin was also observed in an antibiotics-susceptible strain of . Compared with gentamicin monotreatment, the combination group showed a higher intracellular concentration of gentamicin and increased membrane potential in CRKp. Metabolomics analysis indicated remarkable increases of malate and α-ketoglutarate in the tricarboxylic acid (TCA) cycle in the CRKp upon plumbagin treatment. Further analysis revealed higher intracellular NADH concentration in plumbagin-treated CRKp, supporting increased proton-motive force (PMF) that facilitates aminoglycosides uptake.

CONCLUSION

Herbal compound plumbagin was identified to stimulate gentamicin uptake by CRKp via enhancing TCA efflux and PMF to achieve a synergistic antibacterial effect. Plumbagin may be used in combination with aminoglycosides for severe CRKp infection by potentiating their therapeutic efficacy and lowering dosage.

摘要

背景

氨基糖苷类药物是少数可用于耐碳青霉烯类肠杆菌科细菌(CRE)的敏感抗菌药物之一。然而,氨基糖苷类药物药代动力学的改变和耐药性的增加使其在单药治疗时难以发挥有效作用。本研究旨在鉴定能增强庆大霉素对耐碳青霉烯类肺炎克雷伯菌(CRKp)抗菌作用的草药化合物,并探讨其作用机制。

方法

根据临床和实验室标准协会(CLSI)的标准,采用肉汤微量稀释法筛选280种中草药化合物与庆大霉素对CRKp的协同作用。通过液相色谱-串联质谱法(LC-MS/MS)测定细胞内庆大霉素含量。使用细菌膜电位检测试剂盒评估膜电位。采用基于气相色谱-质谱联用仪(GC/MS)的优化非靶向代谢组学方法测定白花丹素诱导的重要代谢途径代谢物变化。通过EnzyChrom NAD/NADH检测试剂盒检测细胞内烟酰胺腺嘌呤二核苷酸(NADH)。

结果

我们发现白花丹素能显著增强庆大霉素对耐庆大霉素的CRKp的抗菌活性。尽管白花丹素对CRKp的最小抑菌作用较弱,但100 μM的白花丹素可使庆大霉素的最低抑菌浓度(MIC)从>16 μg/mL降至约4 μg/mL。在一株抗生素敏感菌株中也观察到白花丹素与庆大霉素具有类似的协同作用。与庆大霉素单药治疗相比,联合治疗组在CRKp中显示出更高的细胞内庆大霉素浓度和增加的膜电位。代谢组学分析表明,白花丹素处理后的CRKp中三羧酸(TCA)循环中的苹果酸和α-酮戊二酸显著增加。进一步分析显示,白花丹素处理的CRKp中细胞内NADH浓度更高,这支持了促进氨基糖苷类药物摄取的质子动力势(PMF)增加。

结论

已鉴定出草药化合物白花丹素可通过增强TCA流出和PMF来刺激CRKp摄取庆大霉素,从而实现协同抗菌作用。白花丹素可通过增强氨基糖苷类药物的治疗效果并降低剂量,用于联合治疗严重的CRKp感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b0/7432958/aab91b809f41/IDR-13-2751-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验